New combo attack on deadly brain Cancer's return
NCT ID NCT03743662
Summary
This study is testing whether adding the immunotherapy drug nivolumab to a standard treatment of focused radiation and the drug bevacizumab is more effective at controlling glioblastoma that has come back. It will involve 39 adults whose brain tumor has returned after initial treatment and has a specific genetic marker. The goal is to see if this combination helps patients live longer by better controlling the cancer's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hartford Healthcare (Data Collection)
Hartford, Connecticut, 06102, United States
-
Indiana University (Data Collection Only)
Indianapolis, Indiana, 46202, United States
-
Lehigh Valley Health Network (Data Collection Only)
Allentown, Pennsylvania, 18103, United States
-
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering Bergen
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Commack
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau
Uniondale, New York, 11553, United States
-
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
-
University of Vermont Medical Center (Data Collection Only)
Burlington, Vermont, 05401, United States
Conditions
Explore the condition pages connected to this study.